EUVIMEDEUVIMED entdecken
Open Access

ERRγ impedes neuroendocrine prostate cancer development

Ting Li iD, Catherine R Dufour iD, Lingwei Han iD, Anthony Alfonso iD, Mirna Farhat iD, Annabelle Beaumier, Qian Chen, Jin-Jian Lu, Vincent Giguère iD

Genes & Development · 2026

DOI: 10.1101/gad.353024.125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Development, 2026. Verfasst von Ting Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Goodman Cancer Institute, McGill University, Montréal, Québec H3A 1A3, Canada; vincent.giguere@mcgill.ca tingli@um.edu.mo. Hauptthemen laut MEDLINE: Receptors, Estrogen, Prostatic Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian Institutes of Health Research, Terry Fox Research Institute, Cancer Research Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine prostate cancer (NEPC) is a lethal subtype of castration-resistant prostate cancer (CRPC). The molecular mechanisms underlying the progression of CRPC toward NEPC remain incompletely understood, and effective treatments remain to be discovered. Here, we report that loss of the nuclear receptor ERRγ promotes neuroendocrine differentiation in a Pten-deficient mouse model of prostate adenocarcinoma. These findings were recapitulated in advanced cellular and xenograft models of human prostate cancer. Critically, we show that ERRγ gain of function can reverse instilled NEPC features accompanied by suppression of growth and oncogenic metabolic reprogramming. Activation of a neuroendocrine transcriptional program enabled by ERRγ deficiency unveiled a targetable vulnerability exploited by the combined pharmacological inhibition of EZH2 and RET kinase that effectively inhibited the growth of ERRγ-deficient tumor organoids and cells. Collectively, our findings demonstrate that ERRγ downregulation facilitates prostate cancer adeno-to-neuroendocrine transformation and offer potential therapeutic strategies to prevent/treat the development of poor outcome NEPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, EstrogenProstatic NeoplasmsCarcinoma, NeuroendocrineMaleAnimalsHumansMiceCell Line, TumorGene Expression Regulation, NeoplasticPTEN PhosphohydrolaseCell DifferentiationDisease Models, Animal

Stichwörter der Autor:innen

ChIP-seqEZH2NEPCPROX1RETRNA-seqadenocarcinomalineage plasticitymetabolismnuclear receptortranscription

Substanzen

Receptors, EstrogenESRRG protein, humanPTEN PhosphohydrolaseEsrrg protein, mouse

Autor:innen und Institutionen

  • Goodman Cancer Institute, McGill University, Montréal, Québec H3A 1A3, Canada; vincent.giguere@mcgill.ca tingli@um.edu.mo.
  • State Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR 999078, China.
  • Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, Macao SAR 999078, China.
  • Goodman Cancer Institute, McGill University, Montréal, Québec H3A 1A3, Canada.
  • Department of Biochemistry, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec H3G 1Y6, Canada.
  • Department of Pharmaceutical Sciences, Faculty of Health Sciences, University of Macau, Macao SAR 999078, China.

ORCID-Profile: Ting Li, Catherine R Dufour, Lingwei Han, Anthony Alfonso, Mirna Farhat, Vincent Giguère

Förderung

  • Canadian Institutes of Health Research
  • Terry Fox Research Institute
  • Cancer Research Society
  • National Natural Science Foundation of China
  • Science and Technology Development Fund, Macau SAR
  • Canderel and Fonds de
  • Recherche du Québec-Santé
  • CIHR

Zitieren

APA

Li, T., Dufour, C. R., Han, L., Alfonso, A., Farhat, M., Beaumier, A., Chen, Q., Lu, J. J., & Giguère, V. (2026). ERRγ impedes neuroendocrine prostate cancer development. Genes & Development. https://doi.org/10.1101/gad.353024.125

Vancouver

Li T, Dufour CR, Han L, Alfonso A, Farhat M, Beaumier A, et al. ERRγ impedes neuroendocrine prostate cancer development. Genes & Development. 2026. doi:10.1101/gad.353024.125

BibTeX
@article{Li2026,
  author = {Li, Ting and Dufour, Catherine R and Han, Lingwei and Alfonso, Anthony and Farhat, Mirna and Beaumier, Annabelle and Chen, Qian and Lu, Jin-Jian and Giguère, Vincent},
  title = {ERRγ impedes neuroendocrine prostate cancer development},
  journal = {Genes & Development},
  year = {2026},
  doi = {10.1101/gad.353024.125}
}
Kostenlos starten →